Business Wire | Apr 20, 2021 06:30AM EDT

Sage Therapeutics to Report First Quarter 2021 Financial Results on Tuesday, May 4, 2021

Apr. 20, 2021

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 20, 2021--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced it will host a live webcast on Tuesday, May 4, 2021 at 8:00 a.m. ET to announce first quarter 2021 financial results and discuss recent business updates.

The webcast can be accessed on the investor page of Sage's website at investor.sagerx.com. A replay of the webcast will be available approximately two hours after the completion of the event and will be archived for up to 30 days.

About Sage TherapeuticsSage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210420005045/en/

CONTACT: Investor Contact Jeff Boyle 617-949-4256 Jeff.Boyle@sagerx.com

CONTACT: Media Contact Maureen L. Suda 617-949-4289 maureen.suda@sagerx.com